Table of Contents Global Gene Therapy for CNS Disorders Professional Survey Report Report 2020, Forecast to 2025 1 Market Overview 1.1 Gene Therapy for CNS Disorders Definition 1.1.1 Analysis of Macroeconomic Indicators 1.1.2 Years Considered 1.2 Gene Therapy for CNS Disorders Segment by Type 1.2.1 Eye Disorders 1.2.2 Hematological Disorders 1.2.3 Central Nervous System Disorders 1.2.4 Muscular Disorders 1.2.5 Others 1.3 Market Analysis by Application 1.3.1 Hospital 1.3.2 Clinic 1.3.3 Research Institute 1.3.4 Others 1.4 Global Gene Therapy for CNS Disorders Market Comparison by Regions (2020-2025) 1.4.1 Global Gene Therapy for CNS Disorders Market Size (2015-2025) 1.4.2 North America Gene Therapy for CNS Disorders Status and Prospect (2015-2025) 1.4.3 Europe Gene Therapy for CNS Disorders Status and Prospect (2015-2025) 1.4.4 Asia-Pacific Gene Therapy for CNS Disorders Status and Prospect (2015-2025) 1.4.5 South America Gene Therapy for CNS Disorders Status and Prospect (2015-2025) 1.4.6 Middle East & Africa Gene Therapy for CNS Disorders Status and Prospect (2015-2025) 1.5 Market Dynamics 1.5.1 Market Opportunities 1.5.2 Market Risk 1.5.3 Market Driving Force 1.5.4 Porter's Five Forces Analysis 1.5.5 SWOT Analysis 1.6 Coronavirus Disease 2019 (Covid-19): Gene Therapy for CNS Disorders Industry Impact 1.6.1 How the Covid-19 is Affecting the Gene Therapy for CNS Disorders Industry 1.6.2 Gene Therapy for CNS Disorders Business Impact Assessment - Covid-19 1.6.3 Market Trends and Gene Therapy for CNS Disorders Potential Opportunities in the COVID-19 Landscape 1.6.4 Measures / Proposal against Covid-19 2 Global Gene Therapy for CNS Disorders Market Competition by Manufacturer 2.1 Global Gene Therapy for CNS Disorders Sales and Market Share by Manufacturer (2018-2020) 2.2 Global Gene Therapy for CNS Disorders Revenue and Market Share by Manufacturer (2018-2020) 2.3 Global Gene Therapy for CNS Disorders Industry Concentration Ratio (CR5 and HHI) 2.4 Top 5 Gene Therapy for CNS Disorders Manufacturer Market Share 2.5 Top 10 Gene Therapy for CNS Disorders Manufacturer Market Share 2.6 Date of Key Manufacturers Enter into Gene Therapy for CNS Disorders Market 2.7 Key Manufacturers Gene Therapy for CNS Disorders Product Offered 2.8 Mergers & Acquisitions Planning 3 Analysis of Gene Therapy for CNS Disorders Industry Key Manufacturers 3.1 BioMarin Pharmaceutical Inc. 3.1.1 Company Details 3.1.2 Product Information 3.1.3 BioMarin Pharmaceutical Inc. Gene Therapy for CNS Disorders Production, Price, Cost, Gross Margin, and Revenue (2018-2020) 3.1.4 Main Business Overview 3.1.5 BioMarin Pharmaceutical Inc. News 3.2 Orchard Therapeutics Plc 3.2.1 Company Details 3.2.2 Product Information 3.2.3 Orchard Therapeutics Plc Gene Therapy for CNS Disorders Production, Price, Cost, Gross Margin, and Revenue (2018-2020) 3.2.4 Main Business Overview 3.2.5 Orchard Therapeutics Plc News 3.3 bluebird bio Inc. 3.3.1 Company Details 3.3.2 Product Information 3.3.3 bluebird bio Inc. Gene Therapy for CNS Disorders Production, Price, Cost, Gross Margin, and Revenue (2018-2020) 3.3.4 Main Business Overview 3.3.5 bluebird bio Inc. News 3.4 Novartis AG 3.4.1 Company Details 3.4.2 Product Information 3.4.3 Novartis AG Gene Therapy for CNS Disorders Production, Price, Cost, Gross Margin, and Revenue (2018-2020) 3.4.4 Main Business Overview 3.4.5 Novartis AG News 3.5 Spark Therapeutics Inc. 3.5.1 Company Details 3.5.2 Product Information 3.5.3 Spark Therapeutics Inc. Gene Therapy for CNS Disorders Production, Price, Cost, Gross Margin, and Revenue (2018-2020) 3.5.4 Main Business Overview 3.5.5 Spark Therapeutics Inc. News 4 Global Gene Therapy for CNS Disorders Market Size Categorized by Regions 4.1 Global Gene Therapy for CNS Disorders Revenue, Sales and Market Share by Regions 4.1.1 Global Gene Therapy for CNS Disorders Sales and Market Share by Regions (2015-2020) 4.1.2 Global Gene Therapy for CNS Disorders Revenue and Market Share by Regions (2015-2020) 4.2 North America Gene Therapy for CNS Disorders Sales and Growth Rate (2015-2020) 4.3 Europe Gene Therapy for CNS Disorders Sales and Growth Rate (2015-2020) 4.4 Asia-Pacific Gene Therapy for CNS Disorders Sales and Growth Rate (2015-2020) 4.5 South America Gene Therapy for CNS Disorders Sales and Growth Rate (2015-2020) 4.6 Middle East & Africa Gene Therapy for CNS Disorders Sales and Growth Rate (2015-2020) 5 North America Gene Therapy for CNS Disorders Market Size Categorized by Countries 5.1 North America Gene Therapy for CNS Disorders Sales, Revenue and Market Share by Countries 5.1.1 North America Gene Therapy for CNS Disorders Sales by Countries (2015-2020) 5.1.2 North America Gene Therapy for CNS Disorders Revenue by Countries (2015-2020) 5.1.3 United States Gene Therapy for CNS Disorders Sales and Growth Rate (2015-2020) 5.1.4 Canada Gene Therapy for CNS Disorders Sales and Growth Rate (2015-2020) 5.1.5 Mexico Gene Therapy for CNS Disorders Sales and Growth Rate (2015-2020) 5.2 North America Gene Therapy for CNS Disorders Revenue (Value) by Manufacturers (2018-2020) 5.3 North America Gene Therapy for CNS Disorders Sales, Revenue and Market Share by Type (2015-2020) 5.3.1 North America Gene Therapy for CNS Disorders Sales Market Share by Type (2015-2020) 5.3.2 North America Gene Therapy for CNS Disorders Revenue and Revenue Share by Type (2015-2020) 5.4 North America Gene Therapy for CNS Disorders Sales Market Share by Application (2015-2020) 6 Europe Gene Therapy for CNS Disorders Market Size Categorized by Countries 6.1 Europe Gene Therapy for CNS Disorders Sales, Revenue and Market Share by Countries 6.1.1 Europe Gene Therapy for CNS Disorders Sales by Countries (2015-2020) 6.1.2 Europe Gene Therapy for CNS Disorders Revenue by Countries (2015-2020) 6.1.3 Germany Gene Therapy for CNS Disorders Sales and Growth Rate (2015-2020) 6.1.4 UK Gene Therapy for CNS Disorders Sales and Growth Rate (2015-2020) 6.1.5 France Gene Therapy for CNS Disorders Sales and Growth Rate (2015-2020) 6.1.6 Russia Gene Therapy for CNS Disorders Sales and Growth Rate (2015-2020) 6.1.7 Italy Gene Therapy for CNS Disorders Sales and Growth Rate (2015-2020) 6.1.8 Spain Gene Therapy for CNS Disorders Sales and Growth Rate (2015-2020) 6.2 Europe Gene Therapy for CNS Disorders Revenue (Value) by Manufacturers (2018-2020) 6.3 Europe Gene Therapy for CNS Disorders Sales, Revenue and Market Share by Type (2015-2020) 6.3.1 Europe Gene Therapy for CNS Disorders Sales Market Share by Type (2015-2020) 6.3.2 Europe Gene Therapy for CNS Disorders Revenue and Revenue Share by Type (2015-2020) 6.4 Europe Gene Therapy for CNS Disorders Sales Market Share by Application (2015-2020) 7 Asia-Pacific Gene Therapy for CNS Disorders Market Size Categorized by Countries 7.1 Asia-Pacific Gene Therapy for CNS Disorders Sales, Revenue and Market Share by Countries 7.1.1 Asia-Pacific Gene Therapy for CNS Disorders Sales by Countries (2015-2020) 7.1.2 Asia-Pacific Gene Therapy for CNS Disorders Revenue by Countries (2015-2020) 7.1.3 China Gene Therapy for CNS Disorders Sales and Growth Rate (2015-2020) 7.1.4 Japan Gene Therapy for CNS Disorders Sales and Growth Rate (2015-2020) 7.1.5 Korea Gene Therapy for CNS Disorders Sales and Growth Rate (2015-2020) 7.1.6 India Gene Therapy for CNS Disorders Sales and Growth Rate (2015-2020) 7.1.7 Southeast Asia Gene Therapy for CNS Disorders Sales and Growth Rate (2015-2020) 7.1.8 Australia Gene Therapy for CNS Disorders Sales and Growth Rate (2015-2020) 7.2 Asia-Pacific Gene Therapy for CNS Disorders Sales and Revenue (Value) by Manufacturers (2018-2020) 7.3 Asia-Pacific Gene Therapy for CNS Disorders Sales, Revenue and Market Share by Type (2015-2020) 7.3.1 Asia-Pacific Gene Therapy for CNS Disorders Sales Market Share by Type (2015-2020) 7.3.2 Asia-Pacific Gene Therapy for CNS Disorders Revenue and Revenue Share by Type (2015-2020) 7.4 Asia-Pacific Gene Therapy for CNS Disorders Sales and Market Share by Application (2015-2020) 8 South America Gene Therapy for CNS Disorders Market Size Categorized by Countries 8.1 South America Gene Therapy for CNS Disorders Sales, Revenue and Market Share by Countries 8.1.1 South America Gene Therapy for CNS Disorders Sales by Countries (2015-2020) 8.1.2 South America Gene Therapy for CNS Disorders Revenue by Countries (2015-2020) 8.1.3 Brazil Gene Therapy for CNS Disorders Sales and Growth Rate (2015-2020) 8.2 South America Gene Therapy for CNS Disorders Revenue (Value) by Manufacturers (2018-2020) 8.3 South America Gene Therapy for CNS Disorders Sales, Revenue and Market Share by Type (2015-2020) 8.3.1 South America Gene Therapy for CNS Disorders Sales Market Share by Type (2015-2020) 8.3.2 South America Gene Therapy for CNS Disorders Revenue and Revenue Share by Type (2015-2020) 8.4 South America Gene Therapy for CNS Disorders Sales Market Share by Application (2015-2020) 9 Middle East and Africa Gene Therapy for CNS Disorders Market Size Categorized by Countries 9.1 Middle East and Africa Gene Therapy for CNS Disorders Sales, Revenue and Market Share by Countries 9.1.1 Middle East and Africa Gene Therapy for CNS Disorders Sales by Countries (2015-2020) 9.1.2 Middle East and Africa Gene Therapy for CNS Disorders Revenue by Countries (2015-2020) 9.1.3 GCC Countries Gene Therapy for CNS Disorders Sales and Growth Rate (2015-2020) 9.1.4 Turkey Gene Therapy for CNS Disorders Sales and Growth Rate (2015-2020) 9.1.5 Egypt Gene Therapy for CNS Disorders Sales and Growth Rate (2015-2020) 9.1.6 South Africa Gene Therapy for CNS Disorders Sales and Growth Rate (2015-2020) 9.2 Middle East and Africa Gene Therapy for CNS Disorders Revenue (Value) by Manufacturers (2018-2020) 9.3 Middle East and Africa Gene Therapy for CNS Disorders Sales, Revenue and Market Share by Type 9.3.1 Middle East and Africa Gene Therapy for CNS Disorders Sales Market Share by Type (2015-2020) 9.3.2 Middle East and Africa Gene Therapy for CNS Disorders Revenue and Revenue Share by Type (2015-2020) 9.4 Middle East and Africa Gene Therapy for CNS Disorders Sales Market Share by Application (2015-2020) 10 Global Gene Therapy for CNS Disorders Market Segment by Type 10.1 Global Gene Therapy for CNS Disorders Revenue, Sales and Market Share by Type (2015-2020) 10.1.1 Global Gene Therapy for CNS Disorders Sales and Market Share by Type (2015-2020) 10.1.2 Global Gene Therapy for CNS Disorders Revenue and Market Share by Type (2015-2020) 10.2 Eye Disorders Sales Growth Rate and Price 10.2.1 Global Eye Disorders Sales Growth Rate (2015-2020) 10.2.2 Global Eye Disorders Price 10.3 Hematological Disorders Sales Growth Rate and Price 10.3.1 Global Hematological Disorders Sales Growth Rate (2015-2020) 10.3.2 Global Hematological Disorders Price 10.4 Central Nervous System Disorders Sales Growth Rate and Price 10.4.1 Global Central Nervous System Disorders Sales Growth Rate (2015-2020) 10.4.2 Global Central Nervous System Disorders Price 10.5 Muscular Disorders Sales Growth Rate and Price 10.5.1 Global Muscular Disorders Sales Growth Rate (2015-2020) 10.5.2 Global Muscular Disorders Price 10.6 Others Sales Growth Rate and Price 10.6.1 Global Others Sales Growth Rate (2015-2020) 10.6.2 Global Others Price 11 Global Gene Therapy for CNS Disorders Market Segment by Application 11.1 Global Gene Therapy for CNS DisordersSales Market Share by Application (2015-2020) 11.2 Hospital Sales Growth Rate (2015-2020) 11.3 Clinic Sales Growth Rate (2015-2020) 11.4 Research Institute Sales Growth Rate (2015-2020) 11.5 Others Sales Growth Rate (2015-2020) 12 Market Forecast for Gene Therapy for CNS Disorders 12.1 Global Gene Therapy for CNS Disorders Revenue, Sales and Growth Rate (2020-2025) 12.2 Gene Therapy for CNS Disorders Market Forecast by Regions (2020-2025) 12.2.1 North America Gene Therapy for CNS Disorders Market Forecast (2020-2025) 12.2.2 Europe Gene Therapy for CNS Disorders Market Forecast (2020-2025) 12.2.3 Asia-Pacific Gene Therapy for CNS Disorders Market Forecast (2020-2025) 12.2.4 South America Gene Therapy for CNS Disorders Market Forecast (2020-2025) 12.2.5 Middle East & Africa Gene Therapy for CNS Disorders Market Forecast (2020-2025) 12.3 Gene Therapy for CNS Disorders Market Forecast by Type (2020-2025) 12.3.1 Global Gene Therapy for CNS Disorders Sales Forecast by Type (2020-2025) 12.3.2 Global Gene Therapy for CNS Disorders Market Share Forecast by Type (2020-2025) 12.4 Gene Therapy for CNS Disorders Market Forecast by Application (2020-2025) 12.4.1 Global Gene Therapy for CNS Disorders Sales Forecast by Application (2020-2025) 12.4.2 Global Gene Therapy for CNS Disorders Market Share Forecast by Application (2020-2025) 13 Gene Therapy for CNS Disorders Related Market Analysis 13.1 Upstream Analysis 13.1.1 Macro Analysis of Upstream Markets 13.1.2 Key Players in Upstream Markets 13.1.3 Upstream Market Trend Analysis 13.1.4 Manufacturing Cost Analysis 13.2 Downstream Market Analysis 13.2.1 Macro Analysis of Down Markets 13.2.2 Key Players in Down Markets 13.2.3 Downstream Market Trend Analysis 13.2.4 Sales Channel, Distributors, Traders and Dealers 14 Research Findings and Conclusion 15 Appendix

List of Tables and Figures Figure Gene Therapy for CNS Disorders Picture Table Global Gene Therapy for CNS Disorders Sales by Type Figure Global Sales Market Share of Gene Therapy for CNS Disorders by Product Type in 2019 Table Breakdown of Gene Therapy for CNS Disorders by Company Type (Tier 1, Tier 2 and Tier 3) Figure Gene Therapy for CNS Disorders Market Share by Company Type (Tier 1, Tier 2 and Tier 3) Figure Eye Disorders Picture Figure Hematological Disorders Picture Figure Central Nervous System Disorders Picture Figure Muscular Disorders Picture Figure Others Picture Table Global Gene Therapy for CNS Disorders Sales by Application Figure Global Gene Therapy for CNS Disorders Sales Market Share by Application in 2019 Figure Hospital Picture Figure Clinic Picture Figure Research Institute Picture Figure Others Picture Table Gene Therapy for CNS Disorders Market Size Comparison by Region (2019-2025) (K Units) & (Million US$) Figure Global Gene Therapy for CNS Disorders Revenue (Million US$) (2015-2025) Figure North America Gene Therapy for CNS Disorders Revenue (Million US$) Growth Rate (2015-2025) Figure Europe Gene Therapy for CNS Disorders Revenue (Million US$) Growth Rate (2015-2025) Figure Asia-Pacific Gene Therapy for CNS Disorders Revenue (Million US$) Growth Rate (2014-2025) Figure South America Gene Therapy for CNS Disorders Revenue (Million US$) Growth Rate (2015-2025) Figure Middle East & Africa Gene Therapy for CNS Disorders Revenue (Million US$) Growth Rate (2015-2025) Table Market Opportunities in Next Few Years Table Market Risks Analysis Table Market Drivers Figure Porter's Five Forces Analysis Table SWOT Analysis Table Global Gene Therapy for CNS Disorders Sales by Manufacturer (2018-2020) Figure Global Gene Therapy for CNS Disorders Sales Market Share by Manufacturer in 2019 Table Global Gene Therapy for CNS Disorders Revenue by Manufacturer (2018-2020) Figure Global Gene Therapy for CNS Disorders Revenue Market Share by Manufacturer in 2019 Table Global Gene Therapy for CNS Disorders Manufacturers Market Concentration Ratio (CR5 and HHI) Figure Top 5 Gene Therapy for CNS Disorders Manufacturer (Revenue) Market Share in 2019 Figure Top 10 Gene Therapy for CNS Disorders Manufacturer (Revenue) Market Share in 2019 Table Date of Key Manufacturers Enter into Gene Therapy for CNS Disorders Market Table Key Manufacturers Gene Therapy for CNS Disorders Product Type Table Mergers & Acquisitions Planning Table BioMarin Pharmaceutical Inc. Company Profile Figure Gene Therapy for CNS Disorders Product Picture and Specifications of BioMarin Pharmaceutical Inc. Table Gene Therapy for CNS Disorders Production, Price, Revenue and Gross Margin of 2018-2020 Figure BioMarin Pharmaceutical Inc. Gene Therapy for CNS Disorders Market Share (2018-2020) Table BioMarin Pharmaceutical Inc. Main Business Table BioMarin Pharmaceutical Inc. Recent Development Table Orchard Therapeutics Plc Company Profile Figure Gene Therapy for CNS Disorders Product Picture and Specifications of Orchard Therapeutics Plc Table Gene Therapy for CNS Disorders Production, Price, Revenue and Gross Margin of 2018-2020 Figure Orchard Therapeutics Plc Gene Therapy for CNS Disorders Market Share (2018-2020) Table Orchard Therapeutics Plc Main Business Table Orchard Therapeutics Plc Recent Development Table bluebird bio Inc. Company Profile Figure Gene Therapy for CNS Disorders Product Picture and Specifications of bluebird bio Inc. Table Gene Therapy for CNS Disorders Production, Price, Revenue and Gross Margin of 2018-2020 Figure bluebird bio Inc. Gene Therapy for CNS Disorders Market Share (2018-2020) Table bluebird bio Inc. Main Business Table bluebird bio Inc. Recent Development Table Novartis AG Company Profile Figure Gene Therapy for CNS Disorders Product Picture and Specifications of Novartis AG Table Gene Therapy for CNS Disorders Production, Price, Revenue and Gross Margin of 2018-2020 Figure Novartis AG Gene Therapy for CNS Disorders Market Share (2018-2020) Table Novartis AG Main Business Table Novartis AG Recent Development Table Spark Therapeutics Inc. Company Profile Figure Gene Therapy for CNS Disorders Product Picture and Specifications of Spark Therapeutics Inc. Table Gene Therapy for CNS Disorders Production, Price, Revenue and Gross Margin of 2018-2020 Figure Spark Therapeutics Inc. Gene Therapy for CNS Disorders Market Share (2018-2020) Table Spark Therapeutics Inc. Main Business Table Spark Therapeutics Inc. Recent Development Figure Global Gene Therapy for CNS Disorders Sales and Growth Rate (2015-2020) Figure Global Gene Therapy for CNS Disorders Revenue and Growth Rate (2015-2020) Table Global Gene Therapy for CNS Disorders Sales by Regions (2015-2020) Figure Global Gene Therapy for CNS Disorders Sales Market Share by Regions in 2019 Table Global Gene Therapy for CNS Disorders Revenue by Regions (2015-2020) Figure Global Gene Therapy for CNS Disorders Revenue Market Share by Regions in 2019 Figure Europe Gene Therapy for CNS Disorders Sales and Growth Rate (2015-2020) Figure Asia-Pacific Gene Therapy for CNS Disorders Sales and Growth Rate (2015-2020) Figure North America Gene Therapy for CNS Disorders Sales and Growth Rate (2015-2020) Figure South America Gene Therapy for CNS Disorders Sales and Growth Rate (2015-2020) Figure Middle East & Africa Gene Therapy for CNS Disorders Sales and Growth Rate (2015-2020) Figure North America Gene Therapy for CNS Disorders Revenue and Growth Rate (2015-2020) Table North America Gene Therapy for CNS Disorders Sales by Countries (2015-2020) Table North America Gene Therapy for CNS Disorders Sales Market Share by Countries (2015-2020) Figure North America Gene Therapy for CNS Disorders Sales Market Share by Countries in 2019 Table North America Gene Therapy for CNS Disorders Revenue by Countries (2015-2020) Table North America Gene Therapy for CNS Disorders Revenue Market Share by Countries (2015-2020) Figure North America Gene Therapy for CNS Disorders Revenue Market Share by Countries in 2019 Figure United States Gene Therapy for CNS Disorders Sales and Growth Rate (2015-2020) Figure Canada Gene Therapy for CNS Disorders Sales and Growth Rate (2015-2020) Figure Mexico Gene Therapy for CNS Disorders Sales and Growth Rate (2015-2020) Table North America Gene Therapy for CNS Disorders Revenue by Manufacturer (2018-2020) Figure North America Gene Therapy for CNS Disorders Revenue Market Share by Manufacturer in 2019 Table North America Gene Therapy for CNS Disorders Sales by Type (2015-2020) Table North America Gene Therapy for CNS Disorders Sales Share by Type (2015-2020) Table North America Gene Therapy for CNS Disorders Revenue by Type (2015-2020) Table North America Gene Therapy for CNS Disorders Revenue Share by Type (2015-2020) Table North America Gene Therapy for CNS Disorders Sales by Application (2015-2020) Table North America Gene Therapy for CNS Disorders Sales Share by Application (2015-2020) Figure Europe Gene Therapy for CNS Disorders Revenue and Growth Rate (2015-2020) Table Europe Gene Therapy for CNS Disorders Sales by Countries (2015-2020) Table Europe Gene Therapy for CNS Disorders Sales Market Share by Countries (2015-2020) Figure Europe Gene Therapy for CNS Disorders Sales Market Share by Countries in 2019 Table Europe Gene Therapy for CNS Disorders Revenue by Countries (2015-2020) Table Europe Gene Therapy for CNS Disorders Revenue Market Share by Countries (2015-2020) Table Europe Gene Therapy for CNS Disorders Revenue Market Share by Countries (2015-2020) Figure Europe Gene Therapy for CNS Disorders Revenue Market Share by Countries in 2019 Figure Germany Gene Therapy for CNS Disorders Sales and Growth Rate (2015-2020) Figure UK Gene Therapy for CNS Disorders Sales and Growth Rate (2015-2020) Figure France Gene Therapy for CNS Disorders Sales and Growth Rate (2015-2020) Figure Russia Gene Therapy for CNS Disorders Sales and Growth Rate (2015-2020) Figure Italy Gene Therapy for CNS Disorders Sales and Growth Rate (2015-2020) Figure Spain Gene Therapy for CNS Disorders Sales and Growth Rate (2015-2020) Table Europe Gene Therapy for CNS Disorders Revenue by Manufacturer (2018-2020) Figure Europe Gene Therapy for CNS Disorders Revenue Market Share by Manufacturer in 2019 Table Europe Gene Therapy for CNS Disorders Sales by Type (2015-2020) Table Europe Gene Therapy for CNS Disorders Sales Share by Type (2015-2020) Table Europe Gene Therapy for CNS Disorders Revenue by Type (2015-2020) Table Europe Gene Therapy for CNS Disorders Revenue Share by Type (2015-2020) Table Europe Gene Therapy for CNS Disorders Sales by Application (2015-2020) Table Europe Gene Therapy for CNS Disorders Sales Share by Application (2015-2020) Figure Asia-Pacific Gene Therapy for CNS Disorders Revenue and Growth Rate (2015-2020) Table Asia-Pacific Gene Therapy for CNS Disorders Sales by Countries (2015-2020) Table Asia-Pacific Gene Therapy for CNS Disorders Sales Market Share by Countries (2015-2020) Figure Asia-Pacific Gene Therapy for CNS Disorders Sales Market Share by Countries in 2019 Table Asia-Pacific Gene Therapy for CNS Disorders Revenue by Countries (2015-2020) Table Asia-Pacific Gene Therapy for CNS Disorders Revenue Market Share by Countries (2015-2020) Figure Asia-Pacific Gene Therapy for CNS Disorders Revenue Market Share by Countries in 2019 Figure China Gene Therapy for CNS Disorders Sales and Growth Rate (2015-2020) Figure Japan Gene Therapy for CNS Disorders Sales and Growth Rate (2015-2020) Figure Korea Gene Therapy for CNS Disorders Sales and Growth Rate (2015-2020) Figure India Gene Therapy for CNS Disorders Sales and Growth Rate (2015-2020) Figure Australia Gene Therapy for CNS Disorders Sales and Growth Rate (2015-2020) Table Asia-Pacific Gene Therapy for CNS Disorders Revenue by Manufacturer (2018-2020) Figure Asia-Pacific Gene Therapy for CNS Disorders Revenue Market Share by Manufacturer in 2019 Table Asia-Pacific Gene Therapy for CNS Disorders Sales by Type (2015-2020) Table Asia-Pacific Gene Therapy for CNS Disorders Sales Share by Type (2015-2020) Table Asia-Pacific Gene Therapy for CNS Disorders Revenue by Type (2015-2020) Table Asia-Pacific Gene Therapy for CNS Disorders Revenue Share by Type (2015-2020) Table Asia-Pacific Gene Therapy for CNS Disorders Sales by Application (2015-2020) Table Asia-Pacific Gene Therapy for CNS Disorders Sales Share by Application (2015-2020) Figure South America Gene Therapy for CNS Disorders Revenue and Growth Rate (2015-2020) Table South America Gene Therapy for CNS Disorders Sales by Countries (2015-2020) Table South America Gene Therapy for CNS Disorders Sales Market Share by Countries (2015-2020) Figure South America Gene Therapy for CNS Disorders Sales Market Share by Countries in 2019 Table South America Gene Therapy for CNS Disorders Revenue by Countries (2015-2020) Table South America Gene Therapy for CNS Disorders Revenue Market Share by Countries (2015-2020) Figure South America Gene Therapy for CNS Disorders Revenue Market Share by Countries in 2019 Figure Brazil Gene Therapy for CNS Disorders Sales and Growth Rate (2015-2020) Table South America Gene Therapy for CNS Disorders Revenue by Manufacturer (2018-2020) Figure South America Gene Therapy for CNS Disorders Revenue Market Share by Manufacturer in 2019 Table South America Gene Therapy for CNS Disorders Sales by Type (2015-2020) Table South America Gene Therapy for CNS Disorders Sales Share by Type (2015-2020) Table South America Gene Therapy for CNS Disorders Revenue by Type (2015-2020) Table South America Gene Therapy for CNS Disorders Revenue Share by Type (2015-2020) Table South America Gene Therapy for CNS Disorders Sales by Application (2015-2020) Table South America Gene Therapy for CNS Disorders Sales Share by Application (2015-2020) Figure Middle East and Africa Gene Therapy for CNS Disorders Revenue and Growth Rate (2015-2020) Table Middle East and Africa Gene Therapy for CNS Disorders Sales by Countries (2015-2020) Table Middle East and Africa Gene Therapy for CNS Disorders Sales Market Share by Countries (2015-2020) Figure Middle East and Africa Gene Therapy for CNS Disorders Sales Market Share by Countries in 2019 Table Middle East and Africa Gene Therapy for CNS Disorders Revenue by Countries (2015-2020) Table Middle East and Africa Gene Therapy for CNS Disorders Revenue Market Share by Countries (2015-2020) Figure Middle East and Africa Gene Therapy for CNS Disorders Revenue Market Share by Countries in 2019 Figure GCC Countries Gene Therapy for CNS Disorders Sales and Growth Rate (2015-2020) Figure Egypt Gene Therapy for CNS Disorders Sales and Growth Rate (2015-2020) Figure Turkey Gene Therapy for CNS Disorders Sales and Growth Rate (2015-2020) Figure South Africa Gene Therapy for CNS Disorders Sales and Growth Rate (2015-2020) Table Middle East and Africa Gene Therapy for CNS Disorders Revenue by Manufacturer (2018-2020) Figure Middle East and Africa Gene Therapy for CNS Disorders Revenue Market Share by Manufacturer in 2019 Table Middle East and Africa Gene Therapy for CNS Disorders Sales by Type (2015-2020) Table Middle East and Africa Gene Therapy for CNS Disorders Sales Share by Type (2015-2020) Table Middle East and Africa Gene Therapy for CNS Disorders Revenue by Type (2015-2020) Table Middle East and Africa Gene Therapy for CNS Disorders Revenue Share by Type (2015-2020) Table Middle East and Africa Gene Therapy for CNS Disorders Sales by Application (2015-2020) Table Middle East and Africa Gene Therapy for CNS Disorders Sales Share by Application (2015-2020) Table Global Gene Therapy for CNS Disorders Sales by Type (2015-2020) Table Global Gene Therapy for CNS Disorders Sales Market Share by Type (2015-2020) Figure Global Gene Therapy for CNS Disorders Sales Market Share by Type in 2019 Table Global Gene Therapy for CNS Disorders Revenue by Type (2015-2020) Table Global Gene Therapy for CNS Disorders Revenue Market Share by Type (2015-2020) Figure Global Gene Therapy for CNS Disorders Revenue Market Share by Type in 2019 Figure Global Eye Disorders Sales Growth Rate (2015-2025) Figure Global Eye Disorders Price (2015-2020) Figure Global Hematological Disorders Sales Growth Rate (2015-2025) Figure Global Hematological Disorders Price (2015-2020) Figure Global Central Nervous System Disorders Sales Growth Rate (2015-2025) Figure Global Central Nervous System Disorders Price (2015-2020) Figure Global Muscular Disorders Sales Growth Rate (2015-2025) Figure Global Muscular Disorders Price (2015-2020) Figure Global Others Sales Growth Rate (2015-2025) Figure Global Others Price (2015-2020) Table Global Gene Therapy for CNS Disorders Sales by Application (2015-2020) Table Global Gene Therapy for CNS Disorders Sales Market Share by Application (2015-2020) Figure Global Gene Therapy for CNS Disorders Sales Market Share by Application in 2019 Figure Global Hospital Sales Growth Rate (2015-2025) Figure Global Clinic Sales Growth Rate (2015-2025) Figure Global Research Institute Sales Growth Rate (2015-2025) Figure Global Others Sales Growth Rate (2015-2025) Figure Global Gene Therapy for CNS Disorders Sales and Growth Rate (2020-2025) Figure Global Gene Therapy for CNS Disorders Revenue and Growth Rate (2020-2025) Table Global Gene Therapy for CNS Disorders Sales Forecast by Regions (2020-2025) Table Global Gene Therapy for CNS Disorders Market Share Forecast by Regions (2020-2025 Figure Europe Sales Gene Therapy for CNS Disorders Market Forecast (2020-2025) Figure Asia-Pacific Sales Gene Therapy for CNS Disorders Market Forecast (2020-2025) Figure North America Sales Gene Therapy for CNS Disorders Market Forecast (2020-2025) Figure South America Sales Gene Therapy for CNS Disorders Market Forecast (2020-2025) Figure Middle East & Africa Sales Gene Therapy for CNS Disorders Market Forecast (2020-2025) Table Global Gene Therapy for CNS Disorders Sales Forecast by Type (2020-2025) Table Global Gene Therapy for CNS Disorders Market Share Forecast by Type (2020-2025) Table Global Gene Therapy for CNS Disorders Sales Forecast by Application (2020-2025) Table Global Gene Therapy for CNS Disorders Market Share Forecast by Application (2020-2025) Table Key Players of Upstream Markets Table Key Raw Materials Figure Price Trend of Key Raw Materials Table Key Suppliers of Raw Materials Figure Manufacturing Cost Structure of Gene Therapy for CNS Disorders Table Key Players of Downstream Markets Figure Sales Channel Figure Methodology/Research Approach Figure Market Size Estimation Figure Author List

BioMarin Pharmaceutical Inc. Orchard Therapeutics Plc bluebird bio Inc. Novartis AG Spark Therapeutics Inc.